Skip to content
June 4, 2025
  • Video
  • Image
  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube

PhaMed

Pharmaceutical & Medical News

Primary Menu

PhaMed

  • Pharma News
    • Global News
    • Shortages
    • Resolved Shortages
    • Discontinued Drugs
  • Business
    • Global Pharma Biz
    • Marketing & Sales
    • Merger
    • Pharma Companies
  • Industries
    • Machianeries
    • Packaging
  • Biotech
  • Research
  • Regulatory Affairs
    • FDA
  • Events
  • Home
  • Uncategorized
  • Tomatoes sold in 3 states now labeled deadly by FDA
  • FDA
  • Uncategorized

Tomatoes sold in 3 states now labeled deadly by FDA

June 2, 2025

Tomatoes sold in 3 states now labeled deadly by FDA

Tomatoes sold in 3 states now labeled deadly by FDA
Read More

About Author

Lloyd Howe

See author's posts

Post Navigation

Previous He Lost 80 Pounds and Reversed His Pre-Diabetes. These 3 Tips Helped Him Do It.
Next Tomato Recall: FDA Issues Highest Alert Over Contaminated Tomatoes

More Stories

  • FDA
  • Uncategorized

FDA Presents Its Case for Targeting Talc

June 3, 2025
  • Uncategorized

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

June 3, 2025
  • Uncategorized

How caregivers of medically complex children build resilience

June 3, 2025

Recent Posts

  • Patient puzzle
  • NICE recommends Sogroya for growth hormone deficiency in children
  • FDA Presents Its Case for Targeting Talc
  • Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
  • How caregivers of medically complex children build resilience

Categories

  • FDA
  • Newsbeat
  • Pharma News
  • Research
  • Selected News
  • Uncategorized
  • Latest
  • Popular
  • Trending
  • Patient puzzle
    • Newsbeat
    • Pharma News

    Patient puzzle

    June 4, 2025 0
  • NICE recommends Sogroya for growth hormone deficiency in children
    • Selected News

    NICE recommends Sogroya for growth hormone deficiency in children

    June 4, 2025
  • FDA Presents Its Case for Targeting Talc
    • FDA
    • Uncategorized

    FDA Presents Its Case for Targeting Talc

    June 3, 2025
  • Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
    • Uncategorized

    Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

    June 3, 2025
  • How caregivers of medically complex children build resilience
    • Uncategorized

    How caregivers of medically complex children build resilience

    June 3, 2025
  • PCN seals off 100 ‘illegal’ medicine shops in Gombe
    • Research

    PCN seals off 100 ‘illegal’ medicine shops in Gombe

    April 4, 2025
  • New study identifies antibodies to enhance whooping cough vaccines
    • Uncategorized

    New study identifies antibodies to enhance whooping cough vaccines

    April 5, 2025
  • Study reveals how aging affects bone cell structure and function
    • Uncategorized

    Study reveals how aging affects bone cell structure and function

    April 5, 2025
  • Scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue
    • Uncategorized

    Scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue

    April 5, 2025
  • FDA Approves First and Only Therapy for IgG4-RD
    • FDA
    • Uncategorized

    FDA Approves First and Only Therapy for IgG4-RD

    April 5, 2025

Categories

FDA Newsbeat Pharma News Research Selected News Uncategorized

CoverNews Social

  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

You may have missed

Patient puzzle
  • Newsbeat
  • Pharma News

Patient puzzle

June 4, 2025 0
NICE recommends Sogroya for growth hormone deficiency in children
  • Selected News

NICE recommends Sogroya for growth hormone deficiency in children

June 4, 2025
FDA Presents Its Case for Targeting Talc
  • FDA
  • Uncategorized

FDA Presents Its Case for Targeting Talc

June 3, 2025
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
  • Uncategorized

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

June 3, 2025
How caregivers of medically complex children build resilience
  • Uncategorized

How caregivers of medically complex children build resilience

June 3, 2025

About PhaMed

We mainly focus on Pharmaceutical News, provided with an elegant design and a broad spectrum. Our news site and automated process of  collecting pharmacy related news, empower you and your business to stay informed about the trends, and to make professional informed decisions for your business.

Recent News

  • Patient puzzle
  • NICE recommends Sogroya for growth hormone deficiency in children
  • FDA Presents Its Case for Targeting Talc
  • Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

Categories

FDA Newsbeat Pharma News Research Selected News Uncategorized
  • Home
  • Business
  • Health
  • Newsbeat
  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
Copyright © All rights reserved. | CoverNews by AF themes.